What are the most promising lifestyle and tech options to harness lifelong neuroplasticity?

By SharpBrains | December 22, 2017

What are the most promis­ing lifestyle and tech options to har­ness life­long neu­ro­plas­tic­i­ty, and what are key road­blocks ahead? (record­ing requires reg­is­tra­tion; view slid­edeck above or Here) Dr. Álvaro Pas­cual-Leone, Direc­tor of the Beren­­son-Allen Cen­ter for Non­in­va­sive Brain Stim­u­la­tion at Beth Israel Dea­coness Med­ical Cen­ter Dr. David Bartrés-Faz, Prin­ci­pal Inves­ti­ga­tor of the Barcelona Brain Health Ini­tia­tive (BBHI) Dr. Simone Schurle, Assistant…

Read More

Dr. Tom Insel and 12 other world-class brain experts confirmed to Speak @ 2017 SharpBrains Virtual Summit (December 5–7th, 2017)

By SharpBrains | September 6, 2017

_______ We are proud to share what’s already shap­ing up to be a quite spec­tac­u­lar and unique Speak­ing Ros­ter at the 2017 Sharp­Brains Vir­tu­al Sum­mit, start­ing with Thomas R. lnsel, MD, a psy­chi­a­trist, neu­ro­sci­en­tist, and cur­rent­ly a co-founder and Pres­i­dent of Mind­strong Health. From 2002–2015, Dr. Insel served as Direc­tor of the Nation­al Insti­tute of Mental…

Read More

Trend: Biopharma embraces digital cognitive assessments to identify behavioral health biomarkers

By SharpBrains | August 14, 2017

_______ The hunt for behav­ioral health bio­mark­ers is har­ness­ing dig­i­tal health at the research stage (Med­C­i­ty News): “Dig­i­tal health com­pa­nies are going through an inter­est­ing trans­for­ma­tion as research insti­tu­tions real­ize the ben­e­fit of their tech­nol­o­gy to col­lect and man­age data for a host of stud­ies. The bio­phar­ma industry’s embrace of some dig­i­tal health tools to manage…

Read More